Medicare does not cover Zepbound for weight loss under standard Part B or Part D rules

Zepbound (tirzepatide) is a prescription medication approved by the FDA for chronic weight management in adults. Medicare Part D plans do not cover it as a weight-loss drug, and Medicare Part B does not cover it either. The reason is straightforward: Medicare's rules exclude medications prescribed solely for weight loss, even when a doctor believes the medication would help a patient's health.

This is a long-standing policy, not a recent change. Medicare treats weight loss differently from other medical conditions — it does not fund drugs for this purpose through either the hospital insurance (Part A) or the medical insurance (Part B) side, and Part D drug plans follow the same exclusion. If your doctor prescribes Zepbound, you pay the full cost out of pocket unless you have other insurance that covers it.

There is one narrow exception: if you have Medicaid (the state program, not Medicare), your state may cover Zepbound, but coverage varies widely by state and by your specific Medicaid plan. This article focuses on Medicare, which has a uniform national rule.

Key Takeaways

  • Medicare Part D plans do not cover Zepbound or other GLP-1 medications when prescribed for weight loss alone.
  • If Zepbound is prescribed for type 2 diabetes management (under the brand name Mounjaro), some Medicare Part D plans may cover it, but you will need to check your specific plan's formulary.
  • The full retail cost of Zepbound is typically $900 to $1,500 per month without insurance, though manufacturer discounts and patient information programs may lower the price.
  • Medicaid (state insurance) may cover Zepbound in some states, but coverage rules differ by state and by individual plan.
  • If your doctor prescribes Zepbound for weight loss, ask about the manufacturer's savings program or discuss lower-cost alternatives with your doctor.

Why Medicare excludes weight-loss medications

Medicare's exclusion of weight-loss drugs is rooted in how the program defines what it will pay for. Medicare covers treatments for diseases and conditions — it does not cover interventions for what it classifies as a cosmetic or lifestyle concern. Weight loss, in Medicare's framework, falls into the latter category, even though obesity is associated with serious health conditions like heart disease, diabetes, and joint problems.

This policy predates Zepbound by decades. It applies to all weight-loss medications, including older drugs like phentermine and orlistat. The exclusion is written into Medicare's national coverage determinations, which are the rules that explore to all beneficiaries across all states and all plans. Individual Medicare Advantage plans (Part C) cannot override this rule — they must follow it.

The policy does not change based on a patient's health status, BMI, or comorbidities. A person with obesity, diabetes, and heart disease still cannot get Medicare coverage for Zepbound prescribed for weight loss. However, the same medication under a different brand name and a different diagnosis can be covered — which creates a confusing situation explained below.

The Mounjaro exception: when the same drug may be covered

Zepbound and Mounjaro are the same active ingredient (tirzepatide), made by the same manufacturer (Eli Lilly). The difference is the indication — the FDA-approved use. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management. Medicare's coverage rule hinges on the indication, not the drug itself.

If your doctor prescribes tirzepatide under the brand name Mounjaro for type 2 diabetes, your Medicare Part D plan may cover it. You will need to check your specific plan's formulary (the list of covered drugs) to see whether Mounjaro is included and what your out-of-pocket cost will be. Some plans cover it with a copay; others require prior authorization (approval from the plan before you fill the prescription); some do not cover it at all.

This creates a gray area: if you have both obesity and type 2 diabetes, and your doctor prescribes tirzepatide, the coverage depends on what your doctor writes as the primary reason for the prescription. If the prescription says "type 2 diabetes management," your Part D plan may cover it. If it says "weight loss" or "chronic weight management," it will not. Your pharmacist will see the indication on the prescription and may flag coverage issues before you pay.

Do not ask your doctor to misrepresent the reason for the prescription to get coverage. Insurers can deny claims if they discover the indication does not match the prescription, and you could be left responsible for the full cost retroactively.

What Zepbound costs without Medicare coverage

The retail price of Zepbound is approximately $900 to $1,500 per month, depending on the dose and your pharmacy. This is the price before any discounts or information. Most people do not pay this full amount because they use a manufacturer discount, a patient information program, or a pharmacy coupon.

Eli Lilly, the manufacturer, offers a savings program called the Zepbound Savings Card. If you are uninsured or your insurance does not cover Zepbound, the card can reduce your out-of-pocket cost to as low as $99 per month for a one-month supply, or $199 per month for a three-month supply. You must meet income requirements to may have access to — the program is designed for people with household income at or below 400% of the federal poverty line, which is roughly $115,000 for a family of four in 2024. The income limits and copay amounts change annually.

Eli Lilly also runs a patient information program for people who do not meet the Savings Card income limits or who need additional help. This program can provide Zepbound at no cost, but the process process is longer and the approval is not may provide. You can find both programs on Eli Lilly's website or ask your doctor's office for help with the process.

How to find out what your specific Medicare plan covers

If your doctor has prescribed Mounjaro (tirzepatide for diabetes), you need to check whether your Medicare Part D plan covers it. Do this before you fill the prescription, not after.

Log into your plan's website and search the formulary for "tirzepatide" or "Mounjaro." The formulary will tell you whether the drug is covered, what tier it is on (which determines your copay), and whether prior authorization is required. If you cannot find it online, call the customer service number on the back of your Medicare card and ask directly.

If your plan does not cover Mounjaro, you have options. You can ask your doctor to prescribe a different diabetes medication that your plan does cover. You can request a formulary exception — a formal request to your plan asking them to cover a drug they normally do not — though approval is not may provide. Or you can switch to a different Medicare Part D plan during the annual open enrollment period (October 15 to December 7 each year) if another plan in your area covers Mounjaro at a lower cost.

If your doctor has prescribed Zepbound specifically for weight loss, there is no formulary to check — Medicare Part D plans do not cover it under any circumstances. Your only options are the manufacturer's savings programs or paying out of pocket.

Medicaid coverage varies by state

Medicaid is a joint federal-state program, which means each state sets its own coverage rules within federal guidelines. Some states have begun covering Zepbound or other GLP-1 medications for weight loss; others have not. Coverage also depends on which Medicaid plan you are enrolled in — some state Medicaid programs offer multiple plans with different drug formularies.

If you are on Medicaid, contact your state's Medicaid program or your specific Medicaid plan to ask whether Zepbound is covered. You can find your state Medicaid office through Medicaid.gov. The answer will depend on your state, your income level, and your specific plan, so there is no single answer that applies everywhere.

Some states that have added Zepbound to their Medicaid formularies have done so recently (within the last year or two), so coverage is still expanding. If your state does not cover it now, that may change, but you cannot rely on that happening.

Alternatives to Zepbound that may have lower costs

If Zepbound is not covered and the cost is too high, talk to your doctor about other options. Older weight-loss medications like phentermine (a stimulant) and orlistat (a fat-absorption blocker) are much cheaper and may be covered by some Medicare Part D plans, though Medicare's general exclusion of weight-loss drugs applies to them as well. These medications are less effective than Zepbound, but they are also significantly less expensive.

If you have type 2 diabetes, your doctor may recommend other GLP-1 medications like semaglutide (Ozempic or Wegovy), dulaglutide (Trulicity), or liraglutide (Saxenda). These have different coverage rules and different costs. Some Medicare Part D plans cover some of these drugs for diabetes; others do not. Wegovy (semaglutide for weight loss) has the same coverage restriction as Zepbound — Medicare does not cover it for weight loss — but it may be cheaper out of pocket or have a different manufacturer information program.

Your doctor can also discuss non-medication approaches: structured diet programs, exercise plans, behavioral therapy, or bariatric surgery. Some of these may have different coverage under Medicare, though weight-loss surgery typically requires meeting specific criteria and often requires prior authorization.

Frequently Asked Questions

Can I get Medicare to cover Zepbound if I have multiple health conditions?

No. Medicare's exclusion of weight-loss medications applies regardless of your other health conditions. Even if you have heart disease, diabetes, and high blood pressure, Medicare will not cover Zepbound prescribed for weight loss. If the same medication is prescribed for diabetes management under a different brand name, that may be covered, but the indication on the prescription matters.

What if my doctor says Zepbound is medically necessary?

A doctor's statement that a medication is medically necessary does not override Medicare's national coverage information. Medicare's rule against covering weight-loss drugs is a policy decision, not a medical judgment. Your doctor can write a letter of medical necessity, but Medicare will not use it to overturn the exclusion. You can file an appeal, but the outcome is unlikely to change the policy.

Does Medicare Advantage cover Zepbound?

Medicare Advantage plans (Part C) must follow Medicare's national coverage rules. They cannot cover Zepbound for weight loss because the federal rule prohibits it. Some Medicare Advantage plans may cover Mounjaro for diabetes, but you will need to check your specific plan's formulary.

If I switch to Medicaid, will it cover Zepbound?

Medicaid coverage of Zepbound depends on your state and your specific plan. Some states cover it; many do not. You would need to contact your state Medicaid program to find out. Switching from Medicare to Medicaid is not straightforward — you would need to lose Medicare may be able to access or may have access to for both programs simultaneously, which has strict income and asset limits.

Can I use the manufacturer's savings card with Medicare?

Yes. If you are on Medicare and Zepbound is not covered by your plan, you can use Eli Lilly's Zepbound Savings Card to reduce your out-of-pocket cost. The card works alongside Medicare — you are not using your Medicare coverage, you are using the manufacturer's discount instead. You must meet the income requirements, which are based on household income, not Medicare status.